Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Anything of value

<< Previous

Bullboard Posts

Next >>

Post by Newinvestor68on Jul 14, 2020 6:27pm

228 Views

Post# 31267896

Anything of value

Let me start by saying that I am doing exactly what I am about to criticize, in hopes of seeing less garbage.

Post information that is accurate, insightful and pertains to this company.

Ridiculous snap crackle and pop comments only make the person typing look like an idiot. Especially when the stock has been halted for weeks with no news and the new prior to that was nothing more than hopes and dreams.

Equally ridiculous is people that obviously have no investment in this stock, yet take their time to dump on it. Guess what your comments will no entice people to sell because they can't. If you do it because you lost money. Lick your wounds and move on.

<< Previous

Bullboard Posts

Next >>

Debt-free cannabis company set for next stage of growth